Related Experiment Video

Updated: Aug 14, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Endocrine disrupting compounds and prostate cancer

J K Hess-Wilson1, K E Knudsen

  • 1Department of Cell Biology, University of Cincinnati College of Medicine, P.O. Box 670521, 3125 Eden Ave., Cincinnati, OH 45267-0521, USA.

Cancer Letters
|November 22, 2005
PubMed

Insights

Endocrine disrupting compounds (EDCs) can affect prostate cancer development and progression. This review examines how agents altering hormone action in the prostate influence cancer growth and treatment strategies.

Area of Science:

  • Oncology
  • Endocrinology
  • Environmental Health

Background:

  • Prostate cancer is a significant health concern.
  • Treatment often relies on the hormone-dependent nature of the cancer.
  • Agents that modify hormone action can influence prostate cancer.

Purpose of the Study:

  • To review the impact of endocrine disrupting compounds (EDCs) on prostate cancer.
  • To explore how agents altering prostate hormone action affect cancer growth.
  • To understand the implications for prostate cancer treatment.

Main Methods:

  • Literature review of studies on endocrine disruptors and prostate cancer.
  • Analysis of agents affecting hormone action in the prostate.
  • Synthesis of findings on cancer development, progression, and treatment response.

Main Results:

  • EDC exposure is linked to alterations in prostate cancer.
  • Specific agents can promote or inhibit cancer growth.
  • Hormone-modulating agents have implications for therapeutic strategies.

Conclusions:

  • Understanding EDC effects is crucial for prostate cancer management.
  • Further research is needed to elucidate specific mechanisms.
  • This knowledge can inform prevention and treatment approaches.

More Related Videos

Methods to Test Endocrine Disruption in Drosophila melanogaster09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Chemical Signaling in the Endocrine System01:08

Chemical Signaling in the Endocrine System

A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...